{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T15:51:12Z","timestamp":1723477872478},"reference-count":2,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/mph.0000000000000080","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T13:28:11Z","timestamp":1386768491000},"page":"e265-e270","source":"Crossref","is-referenced-by-count":7,"title":["High-Dose Cyclophosphamide for the Treatment of Refractory T-Cell Acute Lymphoblastic Leukemia in Children"],"prefix":"10.1097","volume":"36","author":[{"given":"Rachel","family":"Kobos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neerav","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Prockop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Steinherz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R14-19-20210227","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1200\/JCO.2012.45.4728","article-title":"Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.","volume":"31","author":"Gollard","year":"2013","journal-title":"J Clin Oncol"},{"key":"R23-19-20210227","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/1097-0142(196905)23:5<1239::AID-CNCR2820230535>3.0.CO;2-F","article-title":"Evaluation of a high dose cyclophosphamide regimen in childhood tumors.","volume":"23","author":"Finklestein","year":"1969","journal-title":"Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:44:25Z","timestamp":1620963865000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201407000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":2,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000080","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}